Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2OHM

X-ray crystal structure of beta secretase complexed with N~3~-benzylpyridine-2,3-diamine

Summary for 2OHM
Entry DOI10.2210/pdb2ohm/pdb
Related2OF0 2OHK 2OHL 2OHN 2OHP 2OHQ 2OHR 2OHS 2OHT 2OHU
DescriptorBeta-secretase 1, IODIDE ION, DIMETHYL SULFOXIDE, ... (5 entities in total)
Functional Keywordsalternative splicing, alzheimer's disease, aspartic protease, aspartyl protease, base, beta-secretase, glycoprotein, hydrolase, memapsin 2, transmembrane, zymogen
Biological sourceHomo sapiens (human)
Cellular locationMembrane; Single-pass type I membrane protein: P56817
Total number of polymer chains1
Total formula weight45372.59
Authors
Patel, S. (deposition date: 2007-01-10, release date: 2007-03-13, Last modification date: 2024-10-30)
Primary citationMurray, C.W.,Callaghan, O.,Chessari, G.,Cleasby, A.,Congreve, M.,Frederickson, M.,Hartshorn, M.J.,McMenamin, R.,Patel, S.,Wallis, N.
Application of fragment screening by X-ray crystallography to beta-Secretase.
J.Med.Chem., 50:1116-1123, 2007
Cited by
PubMed Abstract: This paper describes an application of fragment screening to the aspartyl protease enzyme, beta-secretase (BACE-1), using high throughput X-ray crystallography. Three distinct chemotypes were identified by X-ray crystallography as binding to the catalytic aspartates either via an aminoheterocycle (such as 2-aminoquinoline), a piperidine, or an aliphatic hydroxyl group. The fragment hits were weak inhibitors of BACE-1 in the millimolar range but were of interest because most of them displayed relatively good ligand efficiencies. The aminoheterocycles exhibited a novel recognition motif that has not been seen before with aspartic proteases. Virtual screening around this motif identified an aminopyridine with increased potency and attractive growth points for further elaboration using structure-based drug design. The companion paper illustrates how sub-micromolar inhibitors were developed starting from this fragment.
PubMed: 17315856
DOI: 10.1021/jm0611962
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.7 Å)
Structure validation

229183

PDB entries from 2024-12-18

PDB statisticsPDBj update infoContact PDBjnumon